ENTITY

CSL (CSL AT)

2
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
•20 Feb 2019 07:43

Aussie Reporting Season Update: February 2019

The Banks remain under earnings pressure from several fronts, with weak credit growth, falling net interest margins and rising compliance costs...

Logo
742 Views
Share
bullish•Terumo Corp
•26 May 2026 08:30

Terumo Corp (4543 JP): FY26 Revenue Hits Record High; Profitability Improvement to Continue

​Terumo exceeds FY26 revenue guidance and achieves record high operating profit. The company expects significant profit growth in FY27 and aims for...

Logo
151 Views
Share
•05 Dec 2018 06:37

Aussie Equities 2019: On a Wing and a Prayer

We expect 2019 will be challenging. Offshore macro and Geopolitical issues emerged in 2018 to dash our expectations of a good year for the Aussie...

Logo
661 Views
Share
•18 Nov 2018 14:21

Low Tide on Aussie Growth Stocks

Growth isn’t Dead Yet. Value’s outperformance in the past couple of months is relatively small compared to past periods and we think the...

Logo
527 Views
Share
•20 Oct 2018 08:35

It’s Not Over Yet, but Lift the Bar on Defence

A Correction and Not the End of the Cycle. In our view, the equity market sell-off in the past few weeks is a correction and a return to more...

Logo
606 Views
Share
x